#USA #Santa Clara #pharmaceutical #Picarro #Hydrogen Peroxide

Picarro Launches the PI2124 Hydrogen Peroxide Analyzer

Picarro Inc., a leading company in high-precision gas concentration analytical solutions, has announced the launch of its latest innovation, the PI2124 Analyzer. This cutting-edge device is designed for monitoring vaporized hydrogen peroxide (VHP) in pharmaceutical and other regulated manufacturing environments. Its continuous and precise measurements can detect VHP levels as low as 3 parts per billion (ppb), thus providing critical support for compliance and operational efficiency.

Importance of VHP Monitoring in Pharmaceuticals

Vaporized hydrogen peroxide is widely utilized in the pharmaceutical and medical device industries, primarily for isolator and equipment decontamination. Ensuring accurate residual VHP concentration measurement is essential for verifying that aeration processes meet safety standards and regulatory requirements. It helps in confirming that production environments remain free from harmful contaminants, which is crucial for maintaining product integrity and compliance with quality regulations.

Picarro's Vice President of Analytical Instruments, Milos Markovic, emphasized that while accurate measurements are vital, the recording and documentation of those measurements are equally important in regulated environments. The PI2124 Analyzer not only offers real-time measurement capabilities but also enhances the process of recording, reviewing, and documenting data, which streamlines compliance workflows without needing to modify existing hardware setups.

Enhanced Features of the PI2124 Analyzer

Continuous Real-Time Monitoring

The PI2124 Analyzer enables continuous, real-time VHP monitoring, delivering actionable insights across various stages of the manufacturing process:

1. Aeration Cycle Monitoring: During the post-decontamination aeration phase, real-time VHP measurements are vital for verifying that concentrations meet the predefined ppb-level target before production starts. By relying on actual concentration data rather than fixed aeration times, operators can determine aeration endpoints dynamically, minimizing unnecessary delays while upholding product standards.
2. Production Campaign Monitoring: Utilizing continuous monitoring during production campaigns helps identify any unforeseen VHP sources that may arise, such as off-gassing from materials within the isolators. The data generated serves as documented evidence to ensure VHP concentrations remain within acceptable limits and facilitates investigations should any irregularities surface.
3. Process Development and Optimization: Historical data collected through the PI2124 can play a vital role in refining aeration cycles for sensitive products. Operators can compare concentration profiles across different production cycles and campaigns to assess process consistency and drive data-informed enhancements in sterilization protocols.

Debuting at ISPE Aseptic Conference

Picarro will present the PI2124 Analyzer at the upcoming ISPE Aseptic Conference, happening on March 23-24, 2026, in Washington, D.C. Attendees are encouraged to visit booth #507 for a live demonstration of the analyzer's capabilities.

About Picarro

For more than 25 years, Picarro has been at the forefront of providing precise solutions for measuring and analyzing hazardous pollutants, greenhouse gases, and trace gases. With a commitment to empowering timely and actionable intelligence, Picarro's innovations span numerous industrial applications, including natural gas distribution, commercial sterilization, and pharmaceutical manufacturing. For further details about Picarro’s advanced solutions, please visit www.picarro.com.

This launch signifies Picarro's ongoing effort to enhance compliance and operational efficiency within industries where product safety and regulatory adherence are paramount. The PI2124 Analyzer not only maintains the integrity of the manufacturing process but also represents a significant advancement in monitoring technology within the pharmaceutical sector.